While using bridging therapy prior to CAR-T cells in myeloma, if possible, do you target a certain response prior to proceeding with cell infusion?

From the moment that you choose to move forward with FDA approved CARVYKTI, you'll need to schedule immune cell collection and lymphodepletion. At my center, it takes approximately 2-4 weeks to get a collection spot during which staff work on insurance submission & approval as well as safety work-up...